Urinary prostaglandin F is generated from the isoprostane pathway and not the cyclooxygenase in humans

Huiyong Yin, Ling Gao, Hsin-Hsiung Tai, Laine J. Murphey, Ned A. Porter, Jason D. Morrow

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

75 Citations (Scopus)
18 Downloads (CityUHK Scholars)

Abstract

Prostaglandins (PGs) derived from the enzymatic oxidation of arachidonic acid by the cyclooxygenases (COXs) are potent lipid mediators involved in human physiology and pathophysiology. Structurally similar compounds, the isoprostanes (IsoPs), are generated from the free radical-catalyzed oxidation of arachidonic acid independent of COX. IsoPs exhibit significant bioactivity and play a role in the pathogenesis of diseases associated with oxidant injury. As one of the major PGs, prostaglandin F(PGF) is present in human urine in significant concentrations and is presumed to be derived from COX activity. We determined, however, that levels of putative PGF in urine cannot be suppressed by nonsteroidal anti-inflammatory agents, suggesting that it is generated via another mechanism(s). An important difference between COX-derived PGF and the IsoPs is that the former is an optically pure compound, whereas IsoPs are racemic. Utilizing a rodent model of oxidative stress, we now show that significant amounts of compounds identical in all respects to PGF and its enantiomer, ent-PGF, are formed in equal amounts esterified in tissue phospholipids, suggesting that these compounds are derived via the IsoP pathway. Further, employing liquid chromatography/mass spectrometry, the vast majority of putative PGF in human urine is derived from the free radical-initiated peroxidation of arachidonate independent of COX and is composed of PGF and its enantiomer, although the latter compound is ∼2-fold more abundant. Thus, quantification of urinary PGF actually reflects oxidative stress status as opposed to COX activity. Indeed, levels of this compound are elevated in urine from cigarette smokers and in humans with hypercholesterolemia, two conditions associated with oxidant stress. The elucidation that urinary PGF in humans is derived from the IsoP pathway has implications regarding PG formation and inhibition in vivo. © 2007 by The American Society for Biochemistry and Molecular Biology, Inc.
Original languageEnglish
Pages (from-to)329-336
JournalJournal of Biological Chemistry
Volume282
Issue number1
DOIs
Publication statusPublished - 5 Jan 2007
Externally publishedYes

Bibliographical note

Publication details (e.g. title, author(s), publication statuses and dates) are captured on an “AS IS” and “AS AVAILABLE” basis at the time of record harvesting from the data source. Suggestions for further amendments or supplementary information can be sent to [email protected].

Publisher's Copyright Statement

  • This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/

Fingerprint

Dive into the research topics of 'Urinary prostaglandin F is generated from the isoprostane pathway and not the cyclooxygenase in humans'. Together they form a unique fingerprint.

Cite this